Can lung adenocarcinoma be treated with osimertinib and Chinese medicine at the same time?
Patients with lung adenocarcinoma can take traditional Chinese medicine for conditioning while taking osimertinib. Osimertinib is an anticancer drug that belongs to the third generation of EGFR tyrosine kinase inhibitors. It has a significant effect in the treatment of non-small cell cancer, especially locally advanced or metastatic non-small cell lung cancer. The main function of this drug is to inhibit the growth and spread of cancer cells. At the same time, traditional Chinese medicine usually uses syndrome differentiation and treatment methods to provide personalized treatment based on the patient's specific symptoms, constitution, and tongue and pulse conditions. Traditional Chinese medicine not only helps regulate the body and enhance the body's resistance, but also effectively alleviates the uncomfortable symptoms caused by cancer.

Although osimertinib and Chinese medicine can be taken at the same time, considering that the effect of Chinese medicine is generally slow, it is recommended that patients take the two drugs half an hour to an hour apart to avoid unnecessary interactions between the drugs and affecting the efficacy of the medicine. In addition, patients should pay close attention to their physical condition during medication and seek medical consultation in time if any adverse reactions or symptoms of intolerance occur.
While patients with lung adenocarcinoma are taking osimertinib, according to the syndrome differentiation and treatment of traditional Chinese medicine, they can choose appropriate traditional Chinese medicine prescriptions for conditioning according to different symptoms. For example, for patients with lung and spleen deficiency, Liujunzi Pills or Shenling Baizhu Powder can be used to replenish qi and strengthen the spleen; while for patients with qi stagnation and blood stasis, Yujin plus Xuefu Zhuyu Decoction can be used to activate blood circulation, remove blood stasis, and promote qi.
It needs to be emphasized that although traditional Chinese medicine plays an indispensable role in the treatment of lung adenocarcinoma, it cannot completely replace Western medicine. While taking osimertinib and traditional Chinese medicine, patients should also receive regular examinations and treatment recommendations from doctors to ensure maximum treatment effects.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)